DoD & Golden Dome — Investment Framework
Last updated: August 26, 2026 · bucket targets unchanged; one rule added, fund versus single name; worked examples and prices as of August 25, 2026 · Research purposes only — not investment advice
Thesis pillars
Golden Dome — funding mechanism
$17.1B of $17.9B in reconciliation
Funding expires Sep 30
$1.75B AMDT3 awarded Jul '26
$151B SHIELD ceiling
Space-based sensors and interceptors, boost-phase kill, AI-enabled C2, hypersonics defense.
The money is not flowing yet. Of the $17.9B FY2027 Golden Dome request, $17.1B sits in the reconciliation request rather than in discretionary appropriations. The administration asked for $350B of defense mandatory funds through reconciliation; the House and Senate budget resolutions carry only $60B. Space Force leadership has warned that a lack of FY2027 funding would stall further development.
Confirmed awards, the evidence that is real: SDA Accelerated Missile Defense Tranche 3, July 13–14, 2026, put $1.75B behind 36 satellites, split
LHX $955M for 18 and Sierra Space $798M for 18, with Intuitive Machines (
LUNR) awarded 18 spacecraft under the same tranche. The MDA SHIELD IDIQ carries a $151B ceiling with more than 1,000 contractors on the vehicle. Space Force named 12 companies for space-based interceptors in April 2026.
NOC and Apex committed $1B of company-funded space-based interceptor development on June 1, 2026, targeting on-orbit capability in 2027 and delivery by 2031.
DoD FY2027 Budget — no enacted bill
No FY2027 appropriation
House CR to Dec 4 (220–205)
Senate CR to Dec 11 (90–6)
$350B ask vs $60B carried
There is no enacted FY2027 defense appropriation. The House passed a continuing resolution through December 4 on July 21 by 220–205. The Senate passed a competing CR through December 11 on August 8 by 90–6. The two are unreconciled. Current funding expires September 30, 2026 and the House returns from recess August 31. September 30 is an expiry date, not a clarity date: the two stopgaps run to December 4 and December 11, and full-year FY2027 appropriations land Q1 to Q2 2027, so the December funding vote is the decision point. The defense appropriations bill cleared House committee markup on June 24, 2026 but has not passed the floor, and the Senate has taken no action on it. DOD has started 21 of the past 27 fiscal years under a CR or a shutdown, and a CR bars new starts and production-rate increases.
Sector context: defense and space names de-rated 30–60% from their May 2026 highs while backlogs grew. That tracks the funding-mechanism gap above, not deteriorating fundamentals.
↓
Screening criteria — click each to expand
% revenue from U.S. government. Backlog trend — book-to-bill >1 required; ideally rising. Prime vs. subcontractor status (primes capture more margin). Backlog as a multiple of annual revenue for visibility.
Rate 1–5 on each architecture layer: space-based sensors, space-based interceptors, boost-phase kill, AI/C2 software, ground radar and terminal defense, directed energy. Total score guides Golden Dome position sizing.
Rate 1–5: loitering munitions (Switchblade class), attritable jet drones/CCA (Valkyrie class), ISR platforms (Puma/Raven class), autonomy software and swarm coordination, counter-UAS hardware or software. NATO export potential is a multiplier.
"Buy American"/NDAA-compliant production. Sole-source or program-of-record status vs. competitive bid. Supply chain risk (rare earths, semiconductors). Prior DoD delivery track record. Management execution on large programs. Government shutdown sensitivity.
Revenue growth YoY. DoD backlog as multiple of annual revenue. Free cash flow conversion. EV/Revenue and EV/EBITDA vs. peer set. Analyst consensus target vs. current price. Important: defense multiples expand on contract momentum — use book-to-bill as the guard rail, not just P/E. Flag when the multiple has "priced in" the thesis.
Live example (August 2026): PLTR trades at $172.75, a $415.13B market cap on $6.16B of revenue and 92.4x forward earnings. It still fails the growth ceiling, so it stays a no-add.
Second worked example: RKLB carries a $40.41B market cap on $769.15M of revenue, about 52x sales against the same 25x ceiling, which is why it is a no-add. Historical marker:
QNT IPO'd at about 450x revenue in June 2026. The June 9
LMT entry window has closed:
LMT is $556.20, about 19.6% below its 52-week high of $692.00.
↓
Portfolio construction
| Bucket | Target % | Criteria | Examples |
|---|
| Growth / pure-plays | 40–45% | Direct program exposure, higher beta, clear contract-to-cash path. Max 25x forward EV/Revenue. | AVAV, KTOS, KRMN, RKLB |
| Core primes | 30–35% | Diversified, dividend-paying, stable backlog, slower growth. Max 3x forward EV/Revenue. | LMT, NOC, RTX, LHX, GD |
| Enablers | 15–20% | Wins regardless of which platform wins; less reconciliation-sensitive. Max 15x. | PSN, MP, DRS, BAH |
| Speculative | 5–10% | Max 3% per name and max 40x; program of record required before adding. | LUNR, RCAT, UMAC, SIDU |
Sector taxonomy — where the newer names sit
| Sector | Name | Bucket | What it is |
|---|
| Missile & hypersonics structures | KRMN | Growth | Karman Holdings. Q2 on August 6, 2026: record revenue $182.1M up 58.2%, backlog $1.3B up 65%, FY26 guidance raised to $730–745M. The Hypersonics and Strategic Missile Defense segment grew 24.2% to $43.4M. An $854M secondary priced at $61.00 on May 28, 2026 sent zero proceeds to the company, which is the supply overhang behind the price. Now held through XAR at 2.96% of the fund rather than as a direct name. |
| Space | LUNR | Speculative | Intuitive Machines. Q2 on August 20, 2026: revenue $206M, roughly 4x year over year, record $1.8B backlog, FY26 guidance $900M–$1B. National security went from 3% to 30% of the revenue mix. H1 free cash flow was −$145.8M and $414M of securities were issued in H1, so it belongs in the speculative bucket only. Now held through XAR at 1.73% of the fund rather than as a direct name, which is the cleanest way to carry a speculative name into a binary funding vote. |
Framework applied — tranche 1 allocation
Tranche 1
5 names
Deployed August 25, 2026
Tranche 2
After the Dec vote
Sized once the December funding vote resolves
Tranche 3
Jan 2027
New tax year
| Bucket | Framework target | Tranche 1 actual | Names |
|---|
| Core primes | 30–35% | 47.4% | LHX, GD, NOC |
| Diversified core | 40–45% growth plus 5–10% speculative, delivered through one fund | 47.9% | XAR · carries KTOS, KRMN, AVAV, DRS and LUNR inside the fund |
| Supply chain | 15–20% enablers | 4.7% | MP · XAR holds no MP inside the fund |
Why primes are deliberately overweight: core primes run at 47.4% against a 30–35% target because current funding expires September 30, 2026 and $17.1B of the $17.9B Golden Dome request sits in reconciliation rather than in appropriations. Diversified, dividend-paying primes absorb a continuing resolution better than pure-plays do.
Why the growth and speculative buckets are now inside a fund: the growth and speculative exposure the old nine-name plan held directly is now carried by XAR, which holds KTOS at 2.65%, KRMN at 2.96%, AVAV at 2.35%, DRS at 1.90% and LUNR at 1.73%, plus 42 more companies. The bucket targets have not moved; only the instrument has. This is a defense, space and supply chain sleeve, since MP Materials is a rare earth miner rather than a defense or space company. Tranche 2 is sized after the December funding vote rather than after September 30; tranche 3 waits for January 2027 and a new tax year. Weights only. Position sizes are omitted from this shared copy. Work with your CPA or advisor before acting.
Fund versus single name — a framework rule
The question
Breadth or precision
A binary policy event argues for breadth
The overlap
19.8%
Eight of the nine single names already sat inside XAR
The rule
Fund as the core
Direct only where the fund cannot express the thesis
Why breadth wins here. The December funding vote is binary: either FY2027 defense money moves or it does not. When the deciding variable is one political outcome rather than company execution, breadth is worth more than precision, because 47 names survive a bad outcome better than five small ones do. That is a judgement about the shape of the risk, not a view on any single company.
Why owning both was redundant. XAR holds eight of the nine names the old plan bought, at a combined 19.8% of the fund: GD 3.05%, KRMN 2.96%, NOC 2.76%, KTOS 2.65%, LHX 2.39%, AVAV 2.35%, DRS 1.90%, LUNR 1.73%. Buying the fund and the singles at the same time bought the same exposure twice and paid single-name concentration risk on top of it.
The rule going forward. Hold the fund as the diversified core. Take a direct position only in one of two cases: the fund's weight is too small to express the thesis, which is why
LHX stays direct at a 2.39% fund weight after winning $955M of the $1.75B SDA Tranche 3 award and trading near its 52-week low; or the fund has no exposure at all, which is why
MP stays direct as the rare earth supply hedge.
GD and
NOC are the narrow third case, kept direct as the dividend anchors, accepting a 3.05% and 2.76% overlap as roughly a 4% add to each rather than a problem worth solving.
What the rule does not say. It does not downgrade the names the fund now carries.
KTOS,
KRMN,
AVAV,
DRS and
LUNR keep their conviction scores and stay on the tracker, because they are still owned, just through the fund rather than beside it.
| Fund fact | XAR | Fund fact | XAR |
|---|
| Price, Aug 25 2026 | $264.85 | Expense ratio | 0.35% |
| Holdings | 47 | Assets | $6.04B |
| Dividend yield | 0.31% | Weighting | Modified equal weight |
| YTD | +9.98% | 1-year | +22.78% |
| Overlap with the direct names | LHX 2.39%, GD 3.05%, NOC 2.76% | MP exposure | None. XAR does not hold MP at all |
Investment modeler — enter your amount
Core Primes (32%)
$80,000
| Ticker | Bucket | Conv. | Alloc. % | Suggested $ | Notes |
| Total |
100% |
$250,000 |
Verify with your advisor before acting. |
Conviction scoring (1–10)
1–2: avoid / story only
3–4: speculative, watch only
5–7: watchlist / staged entry
8–9: high conviction position
Event-based overlay triggers
Sell trigger
Single-day gap up >15% on contract announcement → sell 5% of position into strength same day
Sell trigger
Earnings gap up >10% on defense revenue surprise → sell 5% into strength
Pause trigger
Earnings miss / guidance cut on defense revenue → pause adds 5 trading days, reassess thesis
Pause trigger
Government shutdown >2 weeks → reduce exposure across board; contracts pause
Add trigger
NDAA passage with Golden Dome funding confirmed → reassess upside; add to laggards
Caution flag
Budget CR / no full appropriations → reduce speculative bucket; primes less affected
Time horizons
Near term
Now–90 days
Funding expires Sep 30, but FY2027 clarity does not arrive then; House returns from recess Aug 31; the CRs run to Dec 4 and Dec 11 and the December funding vote is the decision point; RKLB Neutron trim decision Q4
Medium term
6–18 months
Golden Dome awards accelerating off the $1.75B AMDT3 tranche; FY2027 NDAA authorization; full-year appropriations Q1–Q2 2027; tranche 2 sized after the December funding vote
Full thesis
3–5 years
Drone production ramp; full Golden Dome constellation build-out; confirmed award base expanding beyond AMDT3 and SHIELD
AI era thesis — hardware & full-stack advantage beyond defense
Core thesis
Headwind — size small or avoid
Pure SaaS / software
AI generates 40–50%+ of code. Labor deflation compresses margins. Clones spin up in weeks. Pricing power erodes as differentiation becomes replicable at near-zero marginal cost. No physical moat to defend.
Tailwind — prioritize these
Hardware & full-stack
Physical constraints (fabs, chips, energy, sensors, actuators, platform integration) cannot be AI-replaced. AI accelerates these players instead of disrupting them. Harder to commoditize. Harder to clone. Moat grows with capital deployed.
Key insight: AI is an amplifier of capable full-stack systems — not a replacement. Winners own the physical layer (chips, fabs, energy, sensors, actuators, platforms) AND the software that makes it intelligent. The defense framework (
AVAV,
KTOS,
PLTR,
LMT,
NOC) already applies this logic. These are the extension opportunities beyond defense.
AI makes these better, not obsolete. Drones, loitering munitions, CCA wingmen, swarm coordination. Hardware (airframes, propulsion, sensors) plus full-stack integration (edge AI, C2 software) creates durable moats.
AVAV (Switchblade + LOCUST HEL acquisition) and
KTOS (Valkyrie) are highest-conviction public plays in this framework. Defense robotics market ~$22B in 2026, growing to ~$43B by 2035. AI improves perception and autonomy but cannot replace the platform engineering.
Fastest-growing defense hardware subsector. C-UAS market ~$4B in 2026, growing 19–28%/yr. High-energy lasers (HEL) and high-powered microwaves (HPM) provide unlimited-magazine defeat of drone swarms — hardware-intensive, impossible to replicate in software. Key plays:
RTX (Coyote interceptor + KuRFS radar),
AVAV (LOCUST HEL, 20–35kW vehicle-agnostic),
AXON (acquired Dedrone for detection layer). Epirus (private, Leonidas HPM) is the leading private play. DoD May 2026: five U.S. bases selected for directed-energy C-UAS pilot. DroneShield (
DRSHF, OTC) is the most direct pure-play — volatile but growing fast.
Picks and shovels for all AI. NVDA owns GPU training plus the CUDA ecosystem — the clearest current expression of the thesis. TSMC is the fab bottleneck: no alternative exists at leading nodes.
ASML owns EUV lithography (single-source chokepoint). This is the most defensible hardware moat in tech: physical scarcity plus ecosystem lock-in. Also consider MSFT: down 13% YTD as of June 2026, AI ARR growing 123% to $37B — the enterprise AI compounder at the most attractive entry in years.
ASML and TSMC are watchlist candidates for the non-defense bucket.
The ultimate full-stack moat. Quantum hardware (neutral atom, trapped ion, superconducting) cannot be replicated by classical software — physics is the barrier. Leading public plays:
QNT (Quantinuum, IPO June 4, 2026, ~$59/share, $14.5B cap) is the highest-relevance name post-IPO. Sector re-rating underway post-QNT IPO. Defense applications: quantum key distribution, quantum sensing, optimization for targeting and logistics. QNT potential re-entry post-lockup below $55.
AI as amplifier of hardware-intensive systems. Robotics market ~$38B in 2026, growing 30%+ CAGR. Foundation models dramatically improve perception, dexterity, and task adaptability — but cannot replace the mechanical systems, power, actuators, and manufacturing scale. Near-term conviction:
NVDA (Isaac platform + GR00T robotics models),
ISRG (surgical robotics, $8B+ proven revenue, deep regulatory moat), Symbotic/
SYM (warehouse automation, live Walmart deployments). Humanoid players (Figure AI, Apptronik, Boston Dynamics) are mostly private — watch for IPOs. ETFs:
ROBO (diversified),
ARKQ (autonomous tech).
Physical constraint that AI creates explosive demand for. AI data centers consume 10–15x more power per token than traditional compute. Nuclear (
CEG,
VST), grid infrastructure (
ETN), data center REITs (
EQIX,
DLR). DoD is the single largest U.S. government energy consumer — direct bridge from the defense thesis. Less speculative than pure hardware plays: these are cash-flowing businesses with AI demand as an accelerant. Power and cooling are near-term bottlenecks that no software can eliminate.
Screening extension — applying the defense framework outside defense: Look for (1) physical layer ownership — own the hardware, not just software running on it; (2) full-stack integration — harder to disintermediate than a pure API; (3) AI as accelerant, not threat — AI makes their product better, not their competitors cheaper; (4) moat via capital intensity or ecosystem lock-in — fabs, data flywheel, installed base, regulatory approval; (5) real revenue today — avoid stories without cashflow anchors. Flag and reduce: any pure SaaS company without a physical or data moat, single-product AI companies that competitors can clone, and names trading at valuations that already price in 5+ years of perfect execution.
Personal research framework — not investment advice. Review all decisions with your advisor before acting. · View Company Tracker →